Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

SPMF Therapy Curing People With Osteoarthritis all Over the World


News provided by

SBF Healthcare

04 Sep, 2015, 13:55 IST

Share this article

Share toX

Share this article

Share toX

BANGALORE, September 4, 2015 /PRNewswire/ --

SPMF Therapy is a Scientifically-Proven and a non-Surgical Treatment 

Science Beyond Frontiers (SBF) Healthcare and Research Centre inaugurated a new centre in Basaveshwar Nagar, with Mr Gopalaiah K, MLA, Mahalakshmi Layout Vidhanasabh Constituency, as the Chief Guest. At the event, Ms Sunasha from Maldives spoke about her journey and how she suffered from arthritis and was cured with the help of the Sequentially Programmed Magnetic Field (SPMF) Therapy.

AKTISTM SPMFTM Therapy is the world's first scientifically proven, non-surgical treatment to help regenerate cartilage and restore mobility of arthritic knee joints. It has also proven to be extremely effectively in the treatment of certain types of cancer. It is non-invasive, painless and safe. The International Commission for Non-Ionizing Radiation Protection (ICNIRP) has defined emission levels that are considered safe for human use. Both electric and magnetic field emissions from SPMFTM  are well below the levels specified by ICNIRP.

On being asked about the importance of SPMFTM Therapy, Dr VG Vasishta, Wing Commander, and Founder and CEO of SBF Healthcare, said, "OA is caused by progressive degeneration of articular cartilage. Articular cartilage is an avascular anural structure adherent to the articular ends of bone. The continual internal physiological remodelling of cartilage happens due to piezoelectric stimulus i.e., during compression of the cartilage there is generation of weak electro-magnetic fields and thus help in regenerating the cartilage. As such the articular cartilage has very limited regenerative capacity due to limited anabolic capacity and absence of piezo-electric stimulus in osteoarthritis does not allow healing. SPMFTM Therapy restores the missing physiological stimulus thus leading to cartilage regeneration."

Mr Girish IPS, DCP, Bangalore also spoke on the benefits of such therapy, and how people should be encouraged to take the treatment to tackle diseases.

On speaking about the therapy, Mr Gopalaiah K said, "This therapy is a great way to help people overcome osteoarthritis. I hope SBF Healthcare continues discovering such treatments which will help more patients fight other diseases."

The treatment for Osteoarthritis is a 21-days process which requires 60 minutes of the patients' time in total per day. It has been proven to have decreased pain among Osteoarthritis patients without the use of any painkiller drugs, and without any side effects. Both knees can be treated simultaneously, and it is cheaper than knee replacement. It also increases mobility, improves power and stability of the knee joints, while halting the progress of the disease. It does not have effect on co-morbidities (associated medical problems), and patients can carry on their normal activity during the treatment. So far, more than 6000 cases have been treated by SBF Healthcare since its inception.

Osteoarthritis  

Osteoarthritis (OA) is the second-most common rheumatological problem and is the most frequent joint disease with prevalence of 22% to 39% among people. This is the most common cause of locomotor disability in the elderly. Taking into account a billion-plus population, the potential for SPMFTM Therapy is immense.

About the Technology: 

AKTISTM SPMFTM Therapy is a technology that produces highly complex Sequentially Programmed Magnetic Fields, which are computer-controlled and can be precisely focused on to the target tissues with the help of laser guides. These are non-thermal, non-ionizing and have no known side effects.

Exposure to SPMFTM technology sensitizes and re-creates the missing physiological piezoelectric stimulus necessary for cartilage regeneration.

The normal cells are not influenced by the SPMFTM exposure as the Magnetic Field Generators (MFG) are aimed at the target tissue only; furthermore, the signals are modulated depending on the proton density of the target tissue.

About SBF Healthcare: 

It was founded in 2006 by Wing Commander (Dr) V.G.Vasishta (Retd.) soon after his retirement from the Indian Air Force. SBF in India quickly gained popularity as the best healthcare centres in the country for Osteoarthritis treatment and Cancer treatment, owing to unrelenting dedication to excellent medical services and pioneering research in life-saving Osteoarthritis and Cancer medical technologies.
A breakthrough for Osteoarthritis and Cancer patients came with the advent of Sequentially Programmed Magnetic Field (SPMF®) Therapy, SHRC's popularity increased manifold and its Osteoarthritis treatment and cancer treatment regimens won mentions in leading medical journals and publications. Till date, over 6000 cases of Osteoarthritis have been treated and clinical trials on terminally ill Cancer patients have been successfully completed.

For more details log on to: www.sbfhealthcare.com

Media Contact:
Abhishek Saran
[email protected]
+91-9535046900
The PRview


 

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.